{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:36:51Z","timestamp":1771925811283,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21AI109094"],"award-info":[{"award-number":["R21AI109094"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New York Blood Center","award":["NYB000068"],"award-info":[{"award-number":["NYB000068"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI089728"],"award-info":[{"award-number":["R01AI089728"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.vaccine.2014.08.086","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T13:42:20Z","timestamp":1411134140000},"page":"6170-6176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments\u2014The importance of immunofocusing in subunit vaccine design"],"prefix":"10.1016","volume":"32","author":[{"given":"Cuiqing","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Te K","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.08.086_bib0005","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0010","doi-asserted-by":"crossref","first-page":"g2968","DOI":"10.1136\/bmj.g2968","article-title":"WHO voices concern over rising numbers of MERS-CoV cases","volume":"348","author":"Gulland","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.344.6183.457","article-title":"Emerging diseases. Soaring MERS cases in Saudi Arabia raise alarms","volume":"344","author":"Kupferschmidt","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0020","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3201\/eid1911.131172","article-title":"Middle East respiratory syndrome coronavirus in bats, Saudi Arabia","volume":"19","author":"Memish","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0025","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.36.20574","article-title":"Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013","volume":"18","author":"Perera","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1473-3099(13)70164-6","article-title":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study","volume":"13","author":"Reusken","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0035","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","article-title":"Evidence for camel-to-human transmission of MERS coronavirus","volume":"370","author":"Azhar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0040","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3201\/eid2006.140299","article-title":"MERS coronaviruses in dromedary camels, Egypt","volume":"20","author":"Chu","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0045","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid2004.131746","article-title":"Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013","volume":"20","author":"Meyer","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0050","doi-asserted-by":"crossref","first-page":"e01146","DOI":"10.1128\/mBio.01146-14","article-title":"Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia","volume":"5","author":"Briese","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0055","doi-asserted-by":"crossref","first-page":"e00884","DOI":"10.1128\/mBio.01002-14","article-title":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia","volume":"5","author":"Alagaili","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0060","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.24.20502-en","article-title":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013","volume":"18","author":"Mailles","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0065","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.34.20564","article-title":"Investigation of an imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013","volume":"18","author":"Puzelli","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0070","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/JVI.06882-11","article-title":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits","volume":"86","author":"Li","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0085","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1128\/JVI.01277-13","article-title":"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies","volume":"87","author":"Mou","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0090","doi-asserted-by":"crossref","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","article-title":"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0095","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1128\/JVI.01756-13","article-title":"Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus","volume":"87","author":"Chen","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0105","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.med.56.091103.134135","article-title":"Severe acute respiratory syndrome (SARS): a year in review","volume":"56","author":"Skowronski","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","article-title":"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity","volume":"393","author":"Du","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0130","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/vim.2009.0090","article-title":"A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity","volume":"23","author":"Du","year":"2010","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0140","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0145","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development","volume":"87","author":"Du","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0150","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2014.02.004","article-title":"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0155","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1128\/JVI.00433-14","article-title":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein","volume":"88","author":"Du","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0160","doi-asserted-by":"crossref","first-page":"9953","DOI":"10.1128\/JVI.01562-13","article-title":"Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells","volume":"87","author":"Tao","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0165","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.2014.912134","article-title":"Current advancements and potential strategies in the development of MERS-CoV vaccines","volume":"13","author":"Zhang","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0170","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"Song","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0175","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/jit609","article-title":"Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses","volume":"209","author":"Agnihothram","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0180","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0185","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00705-009-0423-8","article-title":"Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors","volume":"154","author":"Martyn","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-4690-4-33","article-title":"Immunogenicity of the outer domain of a HIV-1 clade C gp120","volume":"4","author":"Chen","year":"2007","journal-title":"Retrovirology"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0195","doi-asserted-by":"crossref","first-page":"e53568","DOI":"10.1371\/journal.pone.0053568","article-title":"A critical HA1 neutralizing domain of H5N1influenza in an optimal conformation induces strong cross-protection","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0200","doi-asserted-by":"crossref","first-page":"e16555","DOI":"10.1371\/journal.pone.0016555","article-title":"A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses","volume":"6","author":"Du","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0205","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.vaccine.2006.10.031","article-title":"Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model","volume":"25","author":"Du","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0210","first-page":"129","article-title":"A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses","volume":"7","author":"Li","year":"2013","journal-title":"BioSci Trends"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0215","doi-asserted-by":"crossref","first-page":"234ra59","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0220","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0225","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1128\/JVI.00912-14","article-title":"Exceptionally potent neutralization of middle East respiratory syndrome coronavirus by human monoclonal antibodies","volume":"88","author":"Ying","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0230","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.vaccine.2005.01.033","article-title":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets","volume":"23","author":"Czub","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0235","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.4049\/jimmunol.173.6.4050","article-title":"Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines","volume":"173","author":"He","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0240","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0245","doi-asserted-by":"crossref","first-page":"16598","DOI":"10.1073\/pnas.1310744110","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques","volume":"110","author":"de","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0250","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/infdis\/jit590","article-title":"An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus","volume":"209","author":"Yao","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0255","doi-asserted-by":"crossref","first-page":"e69127","DOI":"10.1371\/journal.pone.0069127","article-title":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters","volume":"8","author":"de","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0260","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1099\/vir.0.060640-0","article-title":"Wild type and innate immune deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus","volume":"95","author":"Coleman","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0265","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/425915a","article-title":"Virology: SARS virus infection of cats and ferrets","volume":"425","author":"Martina","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0270","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters","volume":"79","author":"Roberts","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.08.086_bib0275","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T11:53:12Z","timestamp":1650196392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14012559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":55,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0264410X14012559"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.086","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments\u2014The importance of immunofocusing in subunit vaccine design","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}